# ALLOTAR THERAPEUTICS, INC.: Selective APH1B Modulators as a Novel Therapeutic Strategy for Alzheimer's Disease

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | ALLOTAR THERAPEUTICS, INC. |
| Location | PITTSBURGH, PA |
| Project | Selective APH1B Modulators as a Novel Therapeutic Strategy for Alzheimer's Disease |
| Project number | 1R43AG102306-01 |
| Mechanism | R43 |
| Institute | National Institute on Aging |
| Award | $504,484 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-22 to 2027-09-21 |
| UEI | TC2FSCHYC1P1 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409147). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.